BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2006
View Archived Issues
ALS Association awards research funding to Sirtris
Read More
Safetek signs term sheet with Resdevco
Read More
Dynavax Technologies completes acquisition of Rhein Biotech GmbH
Read More
Apaziquone highly active in superficial bladder cancer
Read More
Teverelix shows promise in phase II prostate cancer study
Read More
Tolterodine improves overactive bladder symptoms and patient quality of life
Read More
SUNRISE study reveals urinary urgency improvement with solifenacin
Read More
hMaxi-K gene transfer for erectile dysfunction safe in phase I study
Read More
Dose proportionality confirmed with BEMA Fentanyl
Read More
Antinociceptive activity of neurotoxin receptor site 2-targeting sodium channel blocker
Read More
Disappointing results from phase III trial of bicifadine in chronic low back pain
Read More
IND approval for Aurora kinase inhibitor AT-9283
Read More
Phase II picoplatin study expanded into Eastern Europe
Read More
Panzem NCD with paclitaxel studied for metastatic breast cancer
Read More
DOD grant supports study of bavituximab in breast cancer
Read More
Enrollment completed in study of Chondrogen to repair tissue in the knee
Read More
PhytoMedical to focus on development of specific polyphenols
Read More
Series B financing at Protez to support development of PZ-601
Read More
Target enrollment completed in phase IIa study of E1-I.N.T. for type 2 diabetes
Read More
New Asian study for Iressa in first-line NSCLC
Read More
Lixivaptan demonstrates aquaretic effects in heart failure patients
Read More
ZT-1 evaluated in vivo, in healthy subjects and in Alzheimer's disease patients
Read More
European approval and recommendation for new Keppra indications
Read More
European approval for Preotact
Read More
Vaprisol launched for treatment of euvolemic hyponatremia
Read More
Roche seeks European approval for novel anemia drug CERA
Read More
Coagulation factor Xa inhibitors prepared and tested at Merck
Read More
Recent Bayer patent imparts novel agents for lipoprotein-related disorders
Read More
Two recent Pfizer patents describe new histamine H3 receptor antagonists
Read More
Newly formed Abraxis Bioscience presents data on nab tumor targeting technology
Read More